Wing Yan So

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Randomized Controlled Trial

Glycemic Control

Natural Killer Cells

Top Venues

EMBO molecular medicine

Science advances

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Wing Yan So, Weiping Han
Gene therapy targeting key beta cell regulators as a potential intervention for diabetes. EMBO molecular medicine 16 (7) (2024)
Wing Yan So, Weiping Han
Gene therapy targeting key beta cell regulators as a potential intervention for diabetes. EMBO molecular medicine 16 (7) (2024)
Wing Yan So, Weiping Han
Gene therapy targeting key beta cell regulators as a potential intervention for diabetes. EMBO molecular medicine (2024)
Wing Yan So, Weiping Han
Gene therapy targeting key beta cell regulators as a potential intervention for diabetes. EMBO molecular medicine 16 (7) (2024)
Wing Yan So, Yilie Liao, Wai Nam Liu, Guy A Rutter, Weiping Han
Paired box 6 gene delivery preserves beta cells and improves islet transplantation efficacy. EMBO molecular medicine (2023)
Wai Nam Liu, Wing Yan So, Sarah L Harden, Shin Yie Fong, Melissa Xin Yu Wong, Wilson Wei Sheng Tan, Sue Yee Tan, Jessica Kai Lin Ong, Ravisankar Rajarethinam, Min Liu, Jia Ying Cheng, Lisda Suteja, Joe Poh Sheng Yeong, N Gopalakrishna Iyer, Darren Wan-Teck Lim, Qingfeng Chen
Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model. Science advances 8 (47) (2022)
Wing Yan So, Wai Nam Liu, Adrian Kee Keong Teo, Guy A Rutter, Weiping Han
Paired box 6 programs essential exocytotic genes in the regulation of glucose-stimulated insulin secretion and glucose homeostasis. Science translational medicine 13 (600) (2021)